Sahar Taqui1, Maros Ferencik1, Brian P Davidson1, J Todd Belcik1, Federico Moccetti1, Michael Layoun1, Jacob Raber2, Mitchell Turker3, Hagai Tavori1, Sergio Fazio1, Jonathan R Lindner4. 1. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. 2. Department of Behavioral Neuroscience and Neurology, Oregon Health & Science University, Portland, Oregon; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon. 3. Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, Oregon. 4. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon. Electronic address: lindnerj@ohsu.edu.
Abstract
BACKGROUND: Microvascular dysfunction (MVD) is a potential cause of chest pain in younger individuals. The authors hypothesized that nonelderly patients referred for computed tomographic angiography (CTA) but without significant stenosis would have a high prevalence of MVD by myocardial contrast echocardiography (MCE). Secondary aims were to test whether the presence of nonobstructive coronary artery disease (CAD) or reduced brachial flow-mediated dilation (FMD) predicted MVD. METHODS: Subjects ≤60 years of age undergoing CTA were recruited if they had either no evidence of coronary plaque or evidence of mild CAD (<50% stenosis) and at least one high-risk plaque feature. Subjects underwent quantitative perfusion imaging using MCE at rest and during regadenoson vasodilator stress. MVD was defined as global or segmental delay of microvascular refill (≥2 sec) during regadenoson. FMD of the brachial artery was also performed. RESULTS: Of the 29 patients in whom MCE could be performed, 12 (41%) had MVD. These subjects, compared with those with normal microvascular function, had lower hyperemic perfusion (mean, 236 ± 68 vs 354 ± 161 intensity units/sec; P = .02) and microvascular flux rate (mean, 1.6 ± 0.4 vs 2.5 ± 0.9 sec-1; P = .002) on quantitative MCE. The degree of FMD was not significantly different in those with or without MVD (mean, 11 ± 4% vs 9 ± 4%; P = .32), and there was a poor correlation between results on stress MCE and FMD. Only eight of the 29 subjects were classified as having nonobstructive CAD. There were no groupwise differences in the prevalence of MVD function in those with versus without CAD (43% vs 38% for negative and positive findings on CTA, respectively, P = .79). CONCLUSIONS: MVD is a common finding in the nonelderly population referred for CTA for evaluation of possible CAD but without obstructive stenosis. Neither the presence of noncritical atherosclerotic disease nor abnormal FMD increases the likelihood for detecting MVD in this population.
BACKGROUND:Microvascular dysfunction (MVD) is a potential cause of chest pain in younger individuals. The authors hypothesized that nonelderly patients referred for computed tomographic angiography (CTA) but without significant stenosis would have a high prevalence of MVD by myocardial contrast echocardiography (MCE). Secondary aims were to test whether the presence of nonobstructive coronary artery disease (CAD) or reduced brachial flow-mediated dilation (FMD) predicted MVD. METHODS: Subjects ≤60 years of age undergoing CTA were recruited if they had either no evidence of coronary plaque or evidence of mild CAD (<50% stenosis) and at least one high-risk plaque feature. Subjects underwent quantitative perfusion imaging using MCE at rest and during regadenoson vasodilator stress. MVD was defined as global or segmental delay of microvascular refill (≥2 sec) during regadenoson. FMD of the brachial artery was also performed. RESULTS: Of the 29 patients in whom MCE could be performed, 12 (41%) had MVD. These subjects, compared with those with normal microvascular function, had lower hyperemic perfusion (mean, 236 ± 68 vs 354 ± 161 intensity units/sec; P = .02) and microvascular flux rate (mean, 1.6 ± 0.4 vs 2.5 ± 0.9 sec-1; P = .002) on quantitative MCE. The degree of FMD was not significantly different in those with or without MVD (mean, 11 ± 4% vs 9 ± 4%; P = .32), and there was a poor correlation between results on stress MCE and FMD. Only eight of the 29 subjects were classified as having nonobstructive CAD. There were no groupwise differences in the prevalence of MVD function in those with versus without CAD (43% vs 38% for negative and positive findings on CTA, respectively, P = .79). CONCLUSIONS: MVD is a common finding in the nonelderly population referred for CTA for evaluation of possible CAD but without obstructive stenosis. Neither the presence of noncritical atherosclerotic disease nor abnormal FMD increases the likelihood for detecting MVD in this population.
Authors: Patricia A Pellikka; Sherif F Nagueh; Abdou A Elhendy; Cathryn A Kuehl; Stephen G Sawada Journal: J Am Soc Echocardiogr Date: 2007-09 Impact factor: 5.251
Authors: Carl J Pepine; R David Anderson; Barry L Sharaf; Steven E Reis; Karen M Smith; Eileen M Handberg; B Delia Johnson; George Sopko; C Noel Bairey Merz Journal: J Am Coll Cardiol Date: 2010-06-22 Impact factor: 24.094
Authors: Rolf Vogel; Andreas Indermühle; Jessica Reinhardt; Pascal Meier; Patrick T Siegrist; Mehdi Namdar; Philipp A Kaufmann; Christian Seiler Journal: J Am Coll Cardiol Date: 2005-03-01 Impact factor: 24.094
Authors: Aaron M From; Garvan Kane; Charles Bruce; Patricia A Pellikka; Christopher Scott; Robert B McCully Journal: J Am Soc Echocardiogr Date: 2010-02 Impact factor: 5.251
Authors: Marcus C de Jong; Tessa S S Genders; Robert-Jan van Geuns; Adriaan Moelker; M G Myriam Hunink Journal: Eur Radiol Date: 2012-04-19 Impact factor: 5.315
Authors: Melinda D Wu; James Hodovan; Kris Kumar; Bart Moulton; Sven Olson; Aubre Gilbert; Matthew D Wood; Jonathan R Lindner Journal: Blood Adv Date: 2020-09-08
Authors: F Groepenhoff; R G M Klaassen; G B Valstar; S H Bots; N C Onland-Moret; H M Den Ruijter; T Leiner; A L M Eikendal Journal: BMC Med Imaging Date: 2021-01-06 Impact factor: 1.930
Authors: Paola Roldan; Sriram Ravi; James Hodovan; J Todd Belcik; Stephen B Heitner; Ahmad Masri; Jonathan R Lindner Journal: Cardiovasc Ultrasound Date: 2022-09-19 Impact factor: 2.263
Authors: Marc Dewey; Maria Siebes; Marc Kachelrieß; Klaus F Kofoed; Pál Maurovich-Horvat; Konstantin Nikolaou; Wenjia Bai; Andreas Kofler; Robert Manka; Sebastian Kozerke; Amedeo Chiribiri; Tobias Schaeffter; Florian Michallek; Frank Bengel; Stephan Nekolla; Paul Knaapen; Mark Lubberink; Roxy Senior; Meng-Xing Tang; Jan J Piek; Tim van de Hoef; Johannes Martens; Laura Schreiber Journal: Nat Rev Cardiol Date: 2020-02-24 Impact factor: 32.419